Haemodynamic definitions and updated clinical classification of pulmonary hypertension
Open accessThe DOI matches its Crossref record; 86 of the 87 references it cites were found in a registry or an index.
Abstract
Since the 1st World Symposium on Pulmonary Hypertension (WSPH) in 1973, pulmonary hypertension (PH) has been arbitrarily defined as mean pulmonary arterial pressure (mPAP) ≥25 mmHg at rest, measured by right heart catheterisation. Recent data from normal subjects has shown that normal mPAP was 14.0±3.3 mmHg. Two standard deviations above this mean value would suggest mPAP >20 mmHg as above the upper limit of normal (above the 97.5th percentile). This definition is no longer arbitrary, but based on a scientific approach. However, this abnormal elevation of mPAP is not sufficient to define pulmonary vascular disease as it can be due to an increase in cardiac output or pulmonary arterial wedge pressure. Thus, this 6th WSPH Task Force proposes to include pulmonary vascular resistance ≥3 Wood Units in the definition of all forms of pre-capillary PH associated with mPAP >20 mmHg. Prospective trials are required to determine whether this PH population might benefit from specific management. Regarding clinical classification, the main Task Force changes were the inclusion in group 1 of a subgroup “pulmonary arterial hypertension (PAH) long-term responders to calcium channel blockers”, due to the specific prognostic and management of these patients, and a subgroup “PAH with overt features of venous/capillaries (pulmonary veno-occlusive disease/pulmonary capillary haemangiomatosis) involvement”, due to evidence suggesting a continuum between arterial, capillary and vein involvement in PAH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![FIGURE 1 The slope of the mean pulmonary arterial pressure (mPAP)–cardiac output (CO) relationship is different in normal control versus pulmonary arterial hypertension (PAH) subjects. Reproduced and modified from [26] with permission.](https://figures.cochat.ai/paper-figures/36e057af8c4544adb1c352faf9a06761/haemodynamic-definitions-and-updated-clinical-classification-of-pulmonary-figure-1.jpg)
![FIGURE 2 Knowledge of the mean pulmonary arterial pressure (mPAP)–cardiac output (CO) relationship does not allow distinction between left heart disease (LHD) and pulmonary vascular disease (PVD) patients; knowledge of exercise pulmonary arterial wedge pressure is also required. TPR: total pulmonary resistance; WU: Wood Units. Reproduced from [29] with permission.](https://figures.cochat.ai/paper-figures/8474dfd09d604465902cbdde1d1fd85a/haemodynamic-definitions-and-updated-clinical-classification-of-pulmonary-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the World Symposium of Pulmonary Hypertension classification of PAH, group 1 is the most common indication.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [62]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Group 2, with decreased left ventricular function, is not an indication for transplantation”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [62]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Pulmonary hypertension can also occur in the context of congenital heart disease.(301)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [301]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“group 3 with PAH and accompanying pathological changes in the lung parenchyma can be considered for transplantation.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [62]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The current consensus is based on 2 tools for referral and listing: the REVEAL Registry 2.2 (Registry to Evaluate Early and Long-term Pulmonary Arterial Hypertension Disease Management 2.0) and 2015 European Society of Cardiology/European Respiratory Society.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [62]
Experimental — accuracy not yet measured
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv317 · Cited by 6,931
Self-citationDe Rosa, S., Samoni, S., Villa, G., & Ronco, C. (2017) · Blood Purification · doi:10.1159/000452650 · Cited by 5,007
Updated clinical classification of pulmonary hypertension
Simonneau, G., Gatzoulis, M. A., Adatia, I., Celermajer, D., Denton, C., Ghofrani, A., Gomez Sanchez, M. A., Krishna Kumar, R., Landzberg, M., Machado, R. F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.029 · Cited by 4,191
Self-citationGaliè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01032-2015 · Cited by 3,172
Self-citationUpdated Clinical Classification of Pulmonary Hypertension
Simonneau, G., Robbins, I. M., Beghetti, M., Channick, R. N., Delcroix, M., Denton, C. P., Elliott, C. G., Gaine, S. P., Gladwin, M. T., Jing, Z.-C., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.012 · Cited by 2,093
Self-citationClinical classification of pulmonary hypertension
Simonneau, G., Galiè, N., Rubin, L. J., Langleben, D., Seeger, W., Domenighetti, G., Gibbs, S., Lebrec, D., Speich, R., Beghetti, M., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.037 · Cited by 1,897
Self-citationDefinitions and Diagnosis of Pulmonary Hypertension
Hoeper, M. M., Bogaard, H. J., Condliffe, R., Frantz, R., Khanna, D., Kurzyna, M., Langleben, D., Manes, A., Satoh, T., Torres, F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.032 · Cited by 1,766
The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension
Rich, S., Kaufmann, E., & Levy, P. S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207093270203 · Cited by 1,550
Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
Gladwin, M. T., Sachdev, V., Jison, M. L., Shizukuda, Y., Plehn, J. F., Minter, K., Brown, B., Coles, W. A., Nichols, J. S., Ernst, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035477 · Cited by 1,325
Guidelines for the diagnosis and treatment of pulmonary hypertension
(2009) · European Respiratory Journal · doi:10.1183/09031936.00139009 · Cited by 1,300
Self-citation
Research works printed but not linked: 2
- Reeves J , Dempsey J , Grover R . Pulmonary circulation during exercise. In: Weir EK , Reeves JT , eds. Pulmonary Vascular Physiology and Physiopathology. New York, Marcel Dekker, 1989; pp. 107–133. · doi:10.1201/9781003573739-5
- Tamura Y , Furukawa A , Li T , et al. Severe pulmonary arterial hypertension in patients treated by Chinese herb nature indigo: Qing-Dai. Poster presentation at the 6th World Symposium on Pulmonary Hypertension, Nice, 2018; A108.
Cited by
Items 201–300 of 1,004
Nikkho, S. M., Richter, M. J., Shen, E., Abman, S. H., Antoniou, K., Chung, J. H., Fernandes, P., Hassoun, P. M., Lazarus, H. M., Olschewski, H., et al. (2022) · Pulmonary Circulation · doi:10.1002/pul2.12127 · Cited by 72
New Drugs and Therapies in Pulmonary Arterial Hypertension
Shah, A. J., Beckmann, T., Vorla, M., & Kalra, D. K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065850 · Cited by 72
Pulmonary complications of Bcr-Abl tyrosine kinase inhibitors
Weatherald, J. C., Bondeelle, L., Chaumais, M., Guignabert, C., Savale, L., Jaïs, X., Sitbon, O., Rousselot, P. H., Humbert, M. J. C., Bergeron, A., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00279-2020 · Cited by 72
Self-citationAli, H.-J. R., Kiernan, M. S., Choudhary, G., LEVINE, D. J., Sodha, N. R., Ehsan, A., & Yousefzai, R. (2019) · ASAIO Journal · doi:10.1097/mat.0000000000001088 · Cited by 71
Recent advances in the management of pulmonary hypertension with interstitial lung disease
Waxman, A. B., Elia, D., Adir, Y., Humbert, M. J. C., & Harari, S. A. (2022) · European Respiratory Review · doi:10.1183/16000617.0220-2021 · Cited by 71
Serum and pulmonary uric acid in pulmonary arterial hypertension
Savale, L., Akagi, S., Tu, L., Cumont, A., Thuillet, R., Phan, C., Vely, B. L., Berrebeh, N., Huertas, A., Jaïs, X., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.00332-2020 · Cited by 70
Self-citationPulmonary arterial hypertension
Boucly, A., Gerges, C., Savale, L., Jaïs, X., Jevnikar, M., Montani, D., Sitbon, O., & Humbert, M. J. C. (2023) · La Presse Médicale · doi:10.1016/j.lpm.2023.104168 · Cited by 70
Self-citationKolaitis, N. A., Zamanian, R. T., Pérez, V. D. J., Badesch, D. B., Benza, R. L., Burger, C. D., Chakinala, M. M., Elwing, J., Feldman, J., Lammi, M. R., et al. (2020) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202007-774oc · Cited by 69
Endothelin and the Cardiovascular System: The Long Journey and Where We Are Going
Haryono, A., Ramadhiani, R., Ryanto, G. R. T., & Emoto, N. (2022) · Biology · doi:10.3390/biology11050759 · Cited by 69
Szucs, B., Szucs, C., Petrekanits, M., & Varga, J. T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184329 · Cited by 69
Current Perspectives on the Physiological Activities of Fermented Soybean-Derived Cheonggukjang
Kim, I.-S., Hwang, C., Yang, W., & Kim, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115746 · Cited by 69
The new haemodynamic definition of pulmonary hypertension: evidence prevails, finally!
Hoeper, M. M., & Humbert, M. J. C. (2019) · European Respiratory Journal · doi:10.1183/13993003.00038-2019 · Cited by 69
Diagnosis and Management of Pulmonary Hypertension in Patients With CKD
Walther, C. P., Nambi, V., Hanania, N. A., & Navaneethan, S. D. (2020) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2019.12.005 · Cited by 68
Challenges and Special Aspects of Pulmonary Hypertension in Middle- to Low-Income Regions
Hasan, B. S., Hansmann, G., Budts, W., Heath, A., Hoodbhoy, Z. A., Jing, Z., Köestenberger, M., Meinel, K., Mocumbi, A. O., Radchenko, G., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.03.047 · Cited by 68
The Effect of Borderline Pulmonary Hypertension on Survival in Chronic Lung Disease
Piccari, L., Wort, S. J., Meloni, F., Rizzo, M., Price, L. C., Martino, L., Salvaterra, E., Scelsi, L., López‐Meseguer, M., Blanco, I., et al. (2022) · Respiration · doi:10.1159/000524263 · Cited by 68
Noninfectious pulmonary complications of haematopoietic stem cell transplantation
Haider, S., Durairajan, N., & Soubani, A. O. (2020) · European Respiratory Review · doi:10.1183/16000617.0119-2019 · Cited by 68
Chauvelot, L., Gamondes, D., Berthiller, J., Nieves, A., Renard, S., Catella, J., Ahmad, K., Bertoletti, L., Camara, B., Gomez, E., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41512 · Cited by 68
Self-citationCare of patients with pulmonary arterial hypertension during the coronavirus (COVID‐19) pandemic
Ryan, J. J., Melendres-Groves, L. D., Zamanian, R. T., Oudiz, R. J., Chakinala, M. M., Rosenzweig, E. B., & Gomberg‐Maitland, M. (2020) · Pulmonary Circulation · doi:10.1177/2045894020920153 · Cited by 67
Wang, J., Li, M., Wang, Q., Zhang, X., Qian, J., Zhao, J., Xu, D., Tian, Z., Wei, W., Zuo, X., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.02157-2019 · Cited by 67
P2X7 Receptor–Mediated Inflammation in Cardiovascular Disease
Zhou, J., Zhou, Z., Liu, X., Yin, H., Tang, Y., & Cao, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.654425 · Cited by 67
Lung-kidney interactions and their role in chronic kidney disease-associated pulmonary diseases
Bollenbecker, S., Czaya, B. A., Gutiérrez, O. M., & Krick, S. (2022) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00152.2021 · Cited by 67
Kant, S., Banerjee, D., Sabe, S. A., Sellke, F. W., & Feng, J. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1110532 · Cited by 67
Novel Imaging Approaches to Cardiac Manifestations of Systemic Inflammatory Diseases
Weber, B., Paik, J. J., Aghayev, A., Klein, A. L., Mavrogeni, S. I., Yu, P. B., & Mukherjee, M. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.09.819 · Cited by 67
Dasgupta, A., Wu, D., Tian, L., Xiong, P. Y., Dunham‐Snary, K. J., Chen, K., Alizadeh, E., Motamed, M., Potus, F., Hindmarch, C. C. T., et al. (2020) · Comprehensive physiology · doi:10.1002/cphy.c190027 · Cited by 67
mTOR Signaling in Pulmonary Vascular Disease: Pathogenic Role and Therapeutic Target
Babicheva, A., Makino, A., & Yuan, J. X. ‐. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042144 · Cited by 67
Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease
Huston, J., & Shah, S. J. (2022) · Circulation Research · doi:10.1161/circresaha.122.319967 · Cited by 66
Post-Pulmonary Embolism Syndrome and Functional Outcomes after Acute Pulmonary Embolism
Luijten, D., de Jong, C. M. M., Ninaber, M. K., Spruit, M. A., Huisman, M. V., & Klok, F. A. (2022) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0042-1749659 · Cited by 66
Pulmonary hypertension in connective tissue diseases: epidemiology, pathogenesis, and treatment
Cansu, D. Ü., & Korkmaz, C. (2022) · Clinical Rheumatology · doi:10.1007/s10067-022-06446-y · Cited by 66
Thomas, C. A., Anderson, R. J., Condon, D. F., & Pérez, V. D. J. (2019) · Pulmonary Therapy · doi:10.1007/s41030-019-00105-5 · Cited by 65
Anaemia, iron homeostasis and pulmonary hypertension: a review
Sonnweber, T., Pizzini, A., Tancevski, I., Löffler-Ragg, J., & Weiss, G. (2020) · Internal and Emergency Medicine · doi:10.1007/s11739-020-02288-1 · Cited by 57
Management of systemic sclerosis: the first five years
Roofeh, D., & Khanna, D. (2020) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000711 · Cited by 65
United States Pulmonary Hypertension Scientific Registry
Badlam, J. B., Badesch, D. B., Austin, E. D., Benza, R. L., Chung, W. K., Farber, H. W., Feldkircher, K., Frost, A., Poms, A. D., Lutz, K. A., et al. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.07.088 · Cited by 65
Wang, M., Liu, Y., Liang, Y. T., Naruse, K., & Takahashi, K. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.649785 · Cited by 64
Harnessing Big Data to Advance Treatment and Understanding of Pulmonary Hypertension
Rhodes, C. J., Sweatt, A. J., & Maron, B. A. (2022) · Circulation Research · doi:10.1161/circresaha.121.319969 · Cited by 64
Evolving Concepts in Endothelial Pathobiology of Pulmonary Arterial Hypertension
Cober, N. D., VandenBroek, M. M., Ormiston, M. L., & Stewart, D. J. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.18261 · Cited by 64
Pharmacotherapy for pulmonary arterial hypertension
Parikh, V. Y., Bhardwaj, A., & Nair, A. P. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.09.14 · Cited by 64
Impact of Nutrition on Pulmonary Arterial Hypertension
Callejo, M., Barberà, J. A., Duarte, J., & Pérez‐Vizcaíno, F. (2020) · Nutrients · doi:10.3390/nu12010169 · Cited by 64
The Genetic Epidemiology of Pediatric Pulmonary Arterial Hypertension
Haarman, M. G., Kerstjens‐Frederikse, W. S., Vissia-Kazemier, T. R., Breeman, K. T. N., Timens, W., Vos, Y. J., Roofthooft, M. T. R., Hillege, H. L., & Berger, R. M. F. (2020) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2020.05.051 · Cited by 64
Lewis, R. A., Armstrong, I. J., Bergbaum, C., Brewis, M. J., Cannon, J. E., Charalampopoulos, A. F., Church, C., Coghlan, G., Davies, R. J., Dimopoulos, K., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00124-2020 · Cited by 64
Lung transplantation for sarcoidosis: outcome and prognostic factors
Pavec, J. L., Valeyre, D., Gazengel, P., Holm, A. M., Schultz, H. H. L., Perch, M., Borgne, A. L., Reynaud‐Gaubert, M., Knoop, C., Godinas, L., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.03358-2020 · Cited by 64
Vascular pathobiology of pulmonary hypertension
Gallardo‐Vara, E., Ntokou, A., Dave, J. M., Jovin, D. G., Saddouk, F. Z., & Greif, D. M. (2022) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2022.12.012 · Cited by 63
Systemic Lupus Erythematosus and Pulmonary Hypertension
Parperis, K. M., Velidakis, N., Khattab, E., Gkougkoudi, E., & Kadoglou, N. P. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065085 · Cited by 63
Thoreau, B., & Mouthon, L. (2023) · Autoimmunity Reviews · doi:10.1016/j.autrev.2023.103506 · Cited by 63
Endothelial to Mesenchymal Transition in Pulmonary Vascular Diseases
Yun, E., Kook, Y., Yoo, K. H., Kim, K. I., Lee, M., Kim, J., & Lee, A. (2020) · Biomedicines · doi:10.3390/biomedicines8120639 · Cited by 63
SPARC, a Novel Regulator of Vascular Cell Function in Pulmonary Hypertension
Veith, C., Vartürk-Özcan, I., Wujak, M., Hadžić, S., Wu, C., Knoepp, F., Kraut, S., Petrovic, A., Gredic, M., Pak, O., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.057001 · Cited by 63
Mimickers of chronic thromboembolic pulmonary hypertension on imaging tests: a review
Narechania, S., Renapurkar, R. D., & Heresi, G. A. (2019) · Pulmonary Circulation · doi:10.1177/2045894019882620 · Cited by 62
Malenfant, S., Lebret, M., Breton-Gagnon, É., Potus, F., Paulin, R., Bonnet, S., & Provencher, S. (2021) · European Respiratory Review · doi:10.1183/16000617.0284-2020 · Cited by 62
Pulmonary Hypertension Caused by Fibrosing Mediastinitis
Wang, A., Su, H., Duan, Y., Jiang, K., Li, Y., Deng, M., Long, X., Wang, H., Zhang, M., Zhang, Y., et al. (2022) · JACC Asia · doi:10.1016/j.jacasi.2021.11.016 · Cited by 62
Vascular–Parenchymal Cross-Talk Promotes Lung Fibrosis through BMPR2 Signaling
Yanagihara, T., Tsubouchi, K., Zhou, Q., Chong, M., Otsubo, K., Isshiki, T., Schupp, J. C., Sato, S., Scallan, C. J., Upagupta, C., et al. (2023) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202109-2174oc · Cited by 62
Lysosomal dysfunction and inflammatory sterol metabolism in pulmonary arterial hypertension
Harvey, L. D., Alotaibi, M., Tai, Y., Tang, Y., Kim, H. J., Kelly, N. J., Sun, W., Woodcock, C.-S. C., Arshad, S., Culley, M. K., et al. (2025) · Science · doi:10.1126/science.adn7277 · Cited by 62
Singh, I., Rahaghi, F. N., Naeije, R., Oliveira, R. K. F., Vanderpool, R. R., Waxman, A. B., & Systrom, D. M. (2019) · Pulmonary Circulation · doi:10.1177/2045894019862435 · Cited by 62
Koudstaal, T., Boomars, K. A., & Kool, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020561 · Cited by 62
Karmouty‐Quintana, H., Thandavarayan, R. A., Keller, S. P., Sahay, S., Pandit, L. M., & Akkanti, B. H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218081 · Cited by 61
Avdeev, S. N., Барбараш, О. Л., Баутин, А. Е., Volkov, A. V., Veselova, T. N., Galyavich, A. S., Goncharova, N. S., Gorbachevsky, S. V., Danilov, N. M., Еременко, А. А., et al. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4683 · Cited by 61
Learning from registries in pulmonary arterial hypertension: pitfalls and recommendations
Swinnen, K., Quarck, R. A., Godinas, L., Belge, C., & Delcroix, M. (2019) · European Respiratory Review · doi:10.1183/16000617.0050-2019 · Cited by 61
Jin, H., Jiao, Y., Guo, L., Ma, Y., Zhao, R., Li, X., Shen, L., Zhou, Z., Kim, S. H., & Liu, J. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4813 · Cited by 61
Sex Differences in Pulmonary Hypertension
Rodríguez-Arias, J. J., & García‐Álvarez, A. (2021) · Frontiers in Aging · doi:10.3389/fragi.2021.727558 · Cited by 60
The role of p53 in the alternation of vascular functions
Chan, G. H. H., Chan, E., Kwok, C. T., Leung, G., Lee, S. M., & Seto, S. W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.981152 · Cited by 60
Jaafar, S., Visovatti, S., Young, A., Huang, S., Cronin, P., Vummidi, D. R., McLaughlin, V. V., & Khanna, D. (2019) · European Respiratory Journal · doi:10.1183/13993003.00586-2019 · Cited by 60
Lu, X., Gong, J., Dennery, P. A., & Yao, H. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.06.021 · Cited by 60
Evaluation and classification of pulmonary arterial hypertension
Sahay, S. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.08.54 · Cited by 60
Xiao, Y., Chen, P., Zhou, R.-L., Zhang, Y., Tian, Z., & Zhang, S. (2020) · Aging and Disease · doi:10.14336/ad.2020.0111 · Cited by 60
Inflammation and immunity in the pathogenesis of hypoxic pulmonary hypertension
Ye, Y., Xu, Q., & Wuren, T. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1162556 · Cited by 59
Dauriat, G., Reynaud‐Gaubert, M., Cottin, V., Lamia, B., Montani, D., Canuet, M., Boissin, C., Tromeur, C., Chaouat, A., Degano, B., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.04.021 · Cited by 59
Self-citationKia, D. S., Kim, K., & Simon, M. A. M. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.641310 · Cited by 59
Long-term health outcomes of preterm birth: a narrative review
Gette, F., Ali, S. A., Ho, M. S. P., Richter, L. L., Chan, E. S., Yang, C. L., Kieran, E. A., Mammen, C., Roberts, A. D., Kang, K. T., et al. (2025) · Frontiers in Pediatrics · doi:10.3389/fped.2025.1565897 · Cited by 58
Skeletal and Respiratory Muscle Dysfunctions in Pulmonary Arterial Hypertension
Riou, M., Pizzimenti, M., Enache, I., Charloux, A., Canuet, M., Andrès, E., Talha, S., Meyer, A., & Gény, B. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020410 · Cited by 58
Tang, W. H. W., Wilcox, J. D., Jacob, M. S., Rosenzweig, E. B., Borlaug, B. A., Frantz, R. P., Hassoun, P. M., Hemnes, A. R., Hill, N. S., Horn, E. M., et al. (2020) · Circulation Heart Failure · doi:10.1161/circheartfailure.119.006363 · Cited by 58
Jankowich, M. D., Maron, B. A., & Choudhary, G. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00072-2 · Cited by 57
Chronic Thromboembolic Pulmonary Hypertension: An Update
Ruaro, B., Baratella, E., Caforio, G., Confalonieri, P., WADE, B. E., Marrocchio, C., Geri, P., Pozzan, R., Andrisano, A. G., Cova, M. A., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12020235 · Cited by 57
Triposkiadis, F. K., Xanthopoulos, A. V., Skoularigis, J. S., & Starling, R. C. (2022) · Heart Failure Reviews · doi:10.1007/s10741-022-10239-5 · Cited by 57
Zeng, C. C., Liu, J., Zheng, X., Hu, X., & He, Y. (2023) · Respiratory Research · doi:10.1186/s12931-023-02559-3 · Cited by 57
Impact of the New Pulmonary Hypertension Definition on Heart Transplant Outcomes
Crawford, T. C., Leary, P. J., Fraser, C. D., Suarez‐Pierre, A., Magruder, J. T., Baumgartner, W. A., Zehr, K. J., Whitman, G. J. R., Masri, S. C., Sheikh, F. H., et al. (2019) · CHEST Journal · doi:10.1016/j.chest.2019.07.028 · Cited by 57
Kökény, G., Calvier, L., Legchenko, E., Chouvarine, P., Mozes, M. M., & Hansmann, G. (2019) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000580 · Cited by 57
Sickle cell disease: at the crossroads of pulmonary hypertension and diastolic heart failure
Wood, K. C., Gladwin, M. T., & Straub, A. C. (2019) · Heart · doi:10.1136/heartjnl-2019-314810 · Cited by 57
Exercise intolerance in chronic thromboembolic pulmonary hypertension after pulmonary angioplasty
Kikuchi, H., Goda, A., Takeuchi, K., Inami, T., Kohno, T., Sakata, K., Soejima, K., & Satoh, T. (2020) · European Respiratory Journal · doi:10.1183/13993003.01982-2019 · Cited by 57
Schistosomiasis Pulmonary Arterial Hypertension
Sibomana, J. P., Campeche, A., de Carvalho‐Filho, R. J., Corrêa, R. D. A., Duani, H., Guimarães, V. P., Hilton, J. F., Kassa, B., Kumar, R., Lee, M. H., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.608883 · Cited by 57
The Role of Regulatory T Cells in Pulmonary Arterial Hypertension
Tian, W., Jiang, S. Y., Jiang, X., Tamošiūnienė, R., Kim, D., Guan, T., Arsalane, S., Pasupneti, S., Voelkel, N. F., Tang, Q., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.684657 · Cited by 57
Ma, B., Cao, Y., Qin, J., Chen, Z., Hu, G., & Li, Q. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103559 · Cited by 56
Bronchopulmonary dysplasia – associated pulmonary hypertension: An updated review
El‐Saie, A., Varghese, N. P., Webb, M. K., Villafranco, N. M., Gandhi, B. B., Guamán, M. C., & Shivanna, B. (2023) · Seminars in Perinatology · doi:10.1016/j.semperi.2023.151817 · Cited by 56
Animals in Respiratory Research
Fröhlich, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052903 · Cited by 56
Kaemmerer, H. M., Gorenflo, M., Huscher, D., Pittrow, D., Apitz, C., Baumgartner, H., Berger, F. F., Bruch, L., Brunnemer, E., Budts, W., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051456 · Cited by 56
Screening for pulmonary arterial hypertension in systemic sclerosis: A systematic literature review.
Bruni, C., Luca, G. D. D., Lazzaroni, M. G., Zanatta, E., Lepri, G., Airó, P., Dagna, L., Doria, A., & Matucci‐Cerinic, M. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.05.042 · Cited by 56
Ventilatory efficiency in pulmonary vascular diseases
Weatherald, J. C., Philipenko, B. S., Montani, D., & Laveneziana, P. (2021) · European Respiratory Review · doi:10.1183/16000617.0214-2020 · Cited by 56
Self-citationMolecular Pathways in Pulmonary Arterial Hypertension
Shah, A. J., Vorla, M., & Kalra, D. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710001 · Cited by 56
Gerhardt, F., Fiessler, E., Olsson, K. M., Kayser, M. Z., Kovács, G., Gall, H. J., Ghofrani, H. A., Eslam, R. B., Lang, I. M., Benjamin, N., et al. (2024) · Circulation · doi:10.1161/circulationaha.122.063821 · Cited by 55
Vascular Remodeling: The Multicellular Mechanisms of Pulmonary Hypertension
Dai, J., Chen, H., Fang, J., Wu, S., & Jia, Z. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094265 · Cited by 55
Imaging of Pulmonary Hypertension
ALTSCHUL, E. L., Rémy-Jardin, M., Machnicki, S. C., Sulica, R., Moore, J., Singh, A. K., & Raoof, S. (2019) · CHEST Journal · doi:10.1016/j.chest.2019.04.003 · Cited by 55
Cardiac function and pulmonary hypertension in Central Asian highlanders at 3250 m
Lichtblau, M., Saxer, S., Furian, M., Mayer, L. C., Bader, P. R., Scheiwiller, P. M., Mademilov, M., Sheraliev, U., Tanner, F. C., Sooronbaev, T., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.02474-2019 · Cited by 55
Characteristics and Long-term Outcomes of Pulmonary Venoocclusive Disease Induced by Mitomycin C
Certain, M. C., Chaumais, M., Jaïs, X., Savale, L., Seferian, A., Parent, F., Georges, M., Favrolt, N., BOURDIN, A. A., Boissin, C., et al. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.09.238 · Cited by 55
Self-citationMicro-RNA Analysis in Pulmonary Arterial Hypertension
Ferreira, C., Abreu, M., Marques, C., Gonçalves, L. M. M., Baptista, R., & Girão, H. M. (2020) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2020.07.008 · Cited by 55
Systemic Sclerosis-Associated Pulmonary Hypertension: Spectrum and Impact
Naranjo, M., & Hassoun, P. M. (2021) · Diagnostics · doi:10.3390/diagnostics11050911 · Cited by 55
Right ventricular function across the spectrum of health and disease
Edward, J. A., Banchs, J. A., Parker, H., & Cornwell, W. K. (2022) · Heart · doi:10.1136/heartjnl-2021-320526 · Cited by 55
Chronic Thromboembolic Disease and Chronic Thromboembolic Pulmonary Hypertension
Lang, I. M., Campean, I., Sadushi‐Kolici, R., Eslam, R. B., Gerges, C., & Skoro‐Sajer, N. (2021) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2020.11.014 · Cited by 53
Diagnosis & management of pulmonary hypertension in congenital diaphragmatic hernia
Bhombal, S., & Patel, N. (2022) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2022.101383 · Cited by 53
Hassan, H. J., Naranjo, M., Ayoub, N., Housten, T., Hsu, S., Balasubramanian, A., Simpson, C. E., Damico, R. L., Mathai, S. C., Kolb, T. M., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202204-0731oc · Cited by 53
DuBrock, H. M. (2023) · CHEST Journal · doi:10.1016/j.chest.2023.01.009 · Cited by 53
Identifying Patients with Pulmonary Arterial Hypertension Using Administrative Claims Algorithms
Mathai, S. C., Hemnes, A. R., Manaker, S., Anguiano, R. H., Dean, B. B., Saundankar, V., Classi, P. M., Nelsen, A. C., Gordon, K., & Ventetuolo, C. E. (2019) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201810-672cme · Cited by 53
Mural Cell SDF1 Signaling Is Associated with the Pathogenesis of Pulmonary Arterial Hypertension
Yuan, K., Liu, Y., Zhang, Y., Nathan, A., Tian, W., Yu, J. E., Sweatt, A. J., Shamskhou, E. A., Condon, D. F., Chakraborty, A., et al. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0401oc · Cited by 53
Clinical characteristics and outcomes of 566 Thais with systemic sclerosis: A cohort study
Foocharoen, C., Peansukwech, U., Mahakkanukrauh, A., Suwannaroj, S., Pongkulkiat, P., Khamphiw, P., & Nanagara, R. (2020) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13859 · Cited by 53
Metadata
- Authors
- Simonneau, G., Montani, D., Celermajer, D. S., Denton, C. P., Gatzoulis, M. A., Krowka, M., Williams, P. G., & Souza, R.
- Affiliations
- Université Paris-Sud (FR)
- The University of Sydney (AU)
- The Royal Free Hospital (GB)
- Mayo Clinic (US)
- Milpark Hospital (ZA)
- ORCID
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2019-01
- Volume
- 53
- Issue
- 1
- Pages
- 1801913
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- PMC
- PMC6351336
- OpenAlex
- W2904180601
- Cited by
- 3,813
- References
- 87
- Citations by year
- 2026: 208 · 2025: 356 · 2024: 480 · 2023: 541 · 2022: 716 · 2021: 711 · 2020: 558 · 2019: 225
- FWCI
- 282.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- European Respiratory Journal (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-10-LABX-0033)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Genetics (clinical) › Vascular Anomalies and Treatments
- Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
- Keywords
- pulmonary hypertension, clinical classification, precapillary pulmonary hypertension, pulmonary arterial hypertension, pulmonary vascular resistance, mean pulmonary artery pressure, pulmonary vascular disease, pulmonary veno-occlusive disease, calcium channel blockers, right heart catheterization, reference values
- MeSH terms
- Consensus Statements as Topic, Heart Diseases, Hemodynamics, Humans, Hypertension, Pulmonary
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.